Regulatory affairs professionals spend a lot of their time doing things that nobody else in the company fully understands. Writing dossiers, tracking agency guidelines, managing submission timelines, negotiating with health authorities. And yet, without that work, no drug reaches the market.
This article looks at how pharmaceutical regulatory affairs is structured inside organisations, what the main roles involve, and what a career in this field actually looks like in practice. If you want a broader introduction to the discipline, the article on what is regulatory affairs in pharma covers the strategic and conceptual foundations.
The structure of a regulatory affairs function
Operational RA vs strategic RA
The distinction is useful, even if in practice the two often overlap. Operational RA deals with the mechanics: preparing and submitting dossiers, tracking deadlines, responding to agency questions, maintaining compliance documentation. Strategic RA sits upstream: choosing the right regulatory pathway, deciding when and how to engage with health authorities, anticipating policy changes that could affect a development programme.
In smaller organisations, the same person does both. In larger ones, these activities tend to be separated across different roles and seniority levels.
How RA teams are organised in pharma companies
There is no single model. Some companies organise their RA function by geography (one team for Europe, one for the US, one for emerging markets). Others organise by product type or therapeutic area. Others still build centralised teams that support all products and regions from a single hub.
What usually stays constant is the internal split between regulatory operations (submissions, systems, archiving) and regulatory strategy (development support, agency interactions, policy monitoring).
RA in big pharma vs smaller biotech
In large pharmaceutical companies, RA is a department with dozens of specialists, each covering a specific geography or product area. There are dedicated regulatory intelligence teams, submission management teams, and separate functions for labelling, advertising and promotion.
In smaller biotech companies, a single regulatory affairs manager might handle everything from CTA preparation to EMA interactions to post-approval reporting. The breadth of exposure is greater; the depth of specialisation is lower. Neither is better. They are simply different environments with different demands.
In-house teams vs external regulatory consultancy
Not all companies maintain a full in-house RA team. Smaller organisations, and sometimes larger ones dealing with specific markets or product types outside their usual scope, rely on external regulatory consultancies. Consultants bring specialised expertise for defined projects: a specific submission, a particular region, a new regulatory pathway the internal team has not dealt with before.
Roles in a pharmaceutical regulatory affairs team
Regulatory Affairs Associate and Specialist
The entry point for most people in the field. Associates and Specialists handle the preparation and compilation of regulatory documents, track submission timelines, manage correspondence with agencies and maintain regulatory databases. The work is detail-intensive and requires solid knowledge of dossier structure, particularly eCTD and CTD formats.
At this level, the learning curve is steep. You are working with complex technical documents across multiple products and geographies, often under tight deadlines. It is where people build the foundational knowledge that everything else rests on.
Regulatory Affairs Manager
Managers take on ownership of specific products or programmes. They develop and implement regulatory strategies, lead interactions with health authorities, and coordinate internally with R&D, medical affairs, quality and commercial teams. They are the main point of contact for a product’s regulatory life within the organisation.
This role requires both technical depth and the ability to communicate clearly with people who do not have a regulatory background. Explaining to a project team why a particular pathway takes eighteen months, or why a specific label claim cannot be supported, is a regular part of the job.
Regulatory Affairs Director and VP of Regulatory Affairs
At director level and above, the focus shifts from managing individual products to shaping the regulatory strategy of the organisation. Directors oversee portfolios, build and develop teams, and represent the company in interactions with senior agency staff. VPs and heads of regulatory affairs often sit on leadership teams and contribute directly to business decisions around development priorities, market entry strategies and pipeline planning.
QPPV: a dedicated regulatory role
The Qualified Person for Pharmacovigilance is a specific regulatory role required by EU legislation for any company holding a marketing authorisation in Europe. The QPPV is personally responsible for the establishment and maintenance of the pharmacovigilance system and has direct reporting obligations to the EMA. It is a named, accountable role, not just a job title, and it carries significant regulatory and legal responsibility.
Regulatory Intelligence Specialist
A more specialised role, found mainly in larger organisations. Regulatory intelligence professionals monitor the global regulatory environment: new guidelines from EMA, FDA and ICH, policy consultations, changes to submission requirements, emerging legislation. They translate this information into internal guidance and feed it into development decisions before it becomes a problem.
Responsibilities across the product lifecycle
Preclinical and early development
RA involvement starts well before the first patient is dosed. During preclinical development, regulatory affairs professionals advise on the testing programmes needed to support regulatory submissions, identify applicable guidelines and flag any product-specific issues that could affect the development pathway. Early input here can save significant time later.
Clinical development: CTA, IND and trial oversight
Before a clinical trial can start in Europe, a Clinical Trial Application must be submitted to the relevant competent authorities. In the US, the equivalent is an Investigational New Drug application filed with the FDA. Preparing these submissions, managing agency responses and overseeing regulatory compliance throughout the trial are core RA responsibilities during clinical development.
Regulatory affairs professionals also contribute to protocol design, ensuring that trial endpoints and data collection approaches will support the eventual marketing authorisation application.
Marketing authorisation: MAA, NDA and regional submissions
The marketing authorisation application is the central regulatory submission: the document that, if approved, allows a product to be placed on the market. In Europe this is the MAA, submitted to the EMA or national competent authorities depending on the procedure. In the US it is the NDA or BLA, submitted to the FDA.
Preparing these dossiers is a major undertaking. A complete MAA runs to hundreds of thousands of pages across multiple modules. Regulatory affairs professionals coordinate the compilation, review the scientific content for regulatory consistency, and manage the submission process across regions.
Post-approval activities
Approval is not the end of the regulatory work; in many ways, it is the beginning of a different phase.
Variations and line extensions
Any change to an approved product, whether it involves the manufacturing process, the formulation, the label or the approved indications, requires a regulatory submission. These are called variations in Europe. Some are minor and can be implemented by notification. Others require full prior approval. Managing the variation portfolio for a marketed product is a continuous and demanding task.
Renewals and PSUR/PBRER submissions
Marketing authorisations in Europe are initially granted for five years and must then be renewed. Alongside this, companies are required to submit periodic safety update reports (PSURs, also called PBRERs under the ICH format) at defined intervals, summarising the benefit-risk profile of the product based on accumulated post-marketing data.
Lifecycle management
Beyond compliance, post-approval regulatory work supports business objectives: seeking approval for new indications, new patient populations, new dosage forms or new routes of administration. Lifecycle management is where regulatory strategy and commercial strategy intersect most directly.
Skills and training for a career in pharmaceutical regulatory affairs
Technical knowledge: the non-negotiables
Regulatory submissions and eCTD/CTD structure
Understanding how a dossier is structured, what goes in each module and how submissions are formatted and published in eCTD is foundational. Without this, everything else is harder.
GxP regulations and compliance
Regulatory affairs professionals need a working knowledge of GMP, GCP and GVP. Not necessarily at the operational depth of a quality manager or a clinical operations specialist, but enough to understand compliance requirements, interpret inspection findings and assess the regulatory impact of quality or clinical issues.
Regulatory intelligence and policy monitoring
The regulatory environment changes constantly. New ICH guidelines, revised EMA reflection papers, FDA guidances, AIFA circulars. Keeping up with these changes, understanding their implications and applying them to real products is a skill that develops over time and distinguishes experienced professionals from those who are still building their knowledge.
Soft skills that matter in RA
Technical knowledge gets you in the door. What determines how far you go is largely something else: the ability to write clearly, to explain complex regulatory requirements to non-specialists, to manage competing priorities, and to hold a position under pressure when a project team is pushing for something that does not have regulatory support.
Influencing without authority is a phrase that gets overused, but it describes something real in regulatory affairs. You often have to stop something, or slow it down, or redirect it, without having direct line authority over the people involved. That requires clarity, credibility and good judgment.
Entry paths and career progression
Academic backgrounds that work
Life sciences degrees are the most common entry point: pharmacy, chemistry, biology, biomedical sciences. Medical degrees and engineering backgrounds also appear, particularly in medical devices regulatory affairs. What matters more than the specific degree is a genuine interest in the regulatory and scientific detail of drug development.
Professional training and development programmes
Formal regulatory affairs training accelerates career development significantly, particularly for those moving from other functions (quality, clinical operations, medical affairs) into regulatory roles. Structured courses covering regulatory strategy, submission preparation, GxP frameworks and health authority interactions provide the technical grounding that is difficult to acquire purely on the job.
LS Academy offers regulatory affairs training programmes designed for professionals working in the pharmaceutical and medical device sectors, covering both foundational topics and specialist areas.
FAQ
Regulatory affairs manages the relationship between a company and health authorities: submissions, approvals, compliance with regulatory requirements. Quality assurance focuses on internal systems and processes that ensure products are manufactured and controlled consistently. The two functions overlap, particularly around GMP compliance and change management, but they have distinct scopes and responsibilities.
It depends on what you value in work. It offers significant intellectual complexity, clear impact on public health outcomes, and strong demand across the industry globally. It is also detail-intensive, deadline-driven and requires comfort with ambiguity, since regulatory requirements are not always clear-cut. For people who like working at the intersection of science, law and strategy, it is a strong career choice.
There is no single required qualification. Most professionals enter with a life sciences degree and build regulatory knowledge through experience and targeted training. Professional development programmes in regulatory affairs, GxP regulations and dossier preparation are widely used to accelerate development, both at entry level and for experienced professionals moving into more senior or specialist roles.
The European Medicines Agency is the central scientific agency responsible for the evaluation and supervision of medicines in the European Union. It coordinates the centralised procedure for marketing authorisation, publishes scientific guidelines that shape development and submission requirements, and oversees the post-marketing surveillance of approved medicines. For any company seeking EU approval, the EMA is the primary regulatory counterpart.